Olga Militano - Children's Oncology Group

基本信息

浏览量：14

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 46 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children

Sumit Gupta, Rachel E Rau,John A Kairalla, Karen R Rabin,Cindy Wang, Anne L Angiolillo,Sarah Alexander, Andrew J Carroll, Susan Conway, Lia Gore,Ilan Kirsch, Holly R Kubaney,Amanda M Li,Jennifer L McNeer,Olga Militano, Tamara P Miller, Yvonne Moyer, Maureen M O'Brien,Maki Okada,Shalini C Reshmi,Mary Shago,Elizabeth Wagner,Naomi Winick, Brent L Wood, Tara Haworth-Wright,Faraz Zaman,Gerhard Zugmaier,Sue Zupanec, Meenakshi Devidas, Stephen P Hunger, David T Teachey,Elizabeth A Raetz, Mignon L Loh

The New England journal of medicine (2024)

引用0浏览0WOS引用

PEPN2312: A Pediatric Early Phase Clinical Trials Network (PEP-CTN) Phase 1 Trial of Imetelstat with Fludarabine/Cytarabine in Pediatric Patients with Relapsed/Refractory AML, MDS, or JMML

Alexandra McLean Stevens, Maureen M. O'Brien,Xiaowei Liu,Charles G Minard,Olga Militano, Joel M Reid, Shyamala Navada,Todd M Cooper, Sarah K. Tasian,Elizabeth Fox,Brenda J. Weigel

Bloodno. Supplement 1 (2024): 4265.4-4265.4

引用0浏览0引用

Methotrexate Scarcity among Children's Oncology Group Institutions: Results of a Multinational Survey

Sarah Menig,Olga Militano,Andrew Ostrenga,M. Brooke Bernhardt,Brittany Lee,Yoram Unguru

ONCOLOGIST (2023)

引用0浏览0WOS引用

Phase 1/2 Study of Tiragolumab and Atezolizumab in Patients with Relapsed or Refractory SMARCB1 or SMARCA4 Deficient Tumors

Mary Frances Wedekind,Srivandana Akshintala,Brigitte C. Widemann,Charles G. Minard,Olga Militano,David Hall, Zanette Bradley,Joel M. Reid,Joseph Gerald Pressey,Elad Sharon,Elizabeth Fox,Brenda Weigel

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)

引用0浏览0引用

Children's Oncology Group's 2023 blueprint for research: Pharmacy

Andrew R Ostrenga,Jennifer Thackray, Ha-Mill H McLearan,Kevin M Mulieri, Elizabeth Bisaccia,Olga Militano,L Lee Dupuis,M Brooke Bernhardt, COG Pharmacy Discipline Steering Committee

Pediatric blood & cancer (2023): e30581-e30581

引用0浏览0WOS引用

PEPN1924, a Phase 2 Study of Trastuzumab Deruxtecan (Ds-8201A, T-DXd) in Adolescents and Young Adults with Recurrent HER2+ Osteosarcoma: A Children’s Oncology Group Pediatric Early-Phase Clinical Trial Network Study

Damon R. Reed,Katherine A. Janeway,Charles G. Minard,David Hall,Brian D. Crompton,Alexander J. Lazar,Wei-Lien Wang,Stephan D. Voss,Olga Militano,Richard Greg Gorlick,Cheryl Ann Pickett-Gies,Elizabeth Fox,Brenda Weigel

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)

引用2浏览0引用

A Phase 1/2 Study of Bay 18953444 (elimusertib) in Pediatric Patients with Relapsed or Refractory Solid Tumors: Initial Report of the Phase 1 Results of PEPN2112

Michael Vincent Ortiz,Julia Lynne Glade Bender,Charles G. Minard,Xiaowei Liu,Kristina Z. Denic,Joel M. Reid,Olga Militano,Alanna J. Church,Alex Kentsis,C. Patrick Reynolds,Stephan D. Voss,Elizabeth Fox,Brenda Weigel

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)

引用0浏览0引用

BLINATUMOMAB ASSOCIATED SEIZURE RISK IN PATIENTS WITH DOWN SYNDROME AND B-LYMPHOBLASTIC LEUKEMIA

Amanda Li,Karen Rabin,John Kairalla,Cindy Wang,Meenakshi Devidas,Olga Militano,Maki Okada,Johann Hitzler,Anne Angiolillo,Elizabeth Raetz,Mignon Loh,Sumit Gupta,Rachel Rau

PEDIATRIC BLOOD & CANCER（2022）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn